KPIs & Operating Metrics(New)
Growth Metrics

Xylem (XYL) EPS (Weighted Average and Diluted) (2016 - 2025)

Xylem has reported EPS (Weighted Average and Diluted) over the past 16 years, most recently at $1.37 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $1.37 for Q4 2025, up 3.01% from a year ago — trailing twelve months through Dec 2025 was $3.92 (up 7.4% YoY), and the annual figure for FY2025 was $3.92, up 7.4%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $1.37 at Xylem, up from $0.93 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for XYL hit a ceiling of $1.37 in Q4 2025 and a floor of $0.07 in Q3 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.63 (2021), compared with a mean of $0.73.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 88.89% in 2022 and later skyrocketed 800.0% in 2023.
  • Xylem's EPS (Weighted Average and Diluted) stood at $0.62 in 2021, then skyrocketed by 32.26% to $0.82 in 2022, then soared by 41.46% to $1.16 in 2023, then rose by 14.66% to $1.33 in 2024, then rose by 3.01% to $1.37 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $1.37 (Q4 2025), $0.93 (Q3 2025), and $0.93 (Q2 2025) per Business Quant data.